Overview

The University of Texas Health Science Center in Houston is hosting a clinical trial on using biological mesh versus synthetic mesh in ventral hernia repairs. They hypothesize that using biological mesh instead of synthetic mesh will have fewer complications one year after surgery. The study’s estimated completion date is March 31, 2022. 

Study Information

This study has an estimated enrollment of 50 participants. Some patients’ hernias will be repaired using a biological mesh and others will be repaired using a synthetic mesh. Researchers will look for complications at the one year and three year mark after surgery. Patient satisfaction will also be evaluated before surgery, one month after surgery, one year after surgery, and three years after surgery.

Inclusion Criteria

All sexes, ages 18 and older, are invited to participate. They must be currently scheduled for an open ventral hernia repair at LBJ General Hospital. 

Exclusion Criteria

Those not allowed to participate include:

• Patients with an active infection.
• Those unlikely to live past the next 2 years, as determined by the surgeon.
• Patients who have other arrangements or surgeries that would complicate receiving a prosthetic mesh.
• Those who will not follow-up (i.e. phone).

Location

Those interested may participate in this study at the University of Texas Health at Lyndon B. Johnson General Hospital in Houston, Texas, 77026. Feel free to contact Mike Liang, M.D. at 713-566-5095 or at Mike.K.Liang@uth.tmc.edu with any questions or concerns.

Sponsors/Collaborators

This clinical trial is sponsored by the University of Texas Health Science Center, Houston with Mike Liang, M.D as the Principal Investigator.